Recursion made these predictions public in **April** In the future there’s zero reason why CMOs won’t require the below validation before unlocking $100s of millions in clinical development budget & costs Until then, I’ll have my Robinhood account primed and ready to go ;)https://twitter.com/RecursionPharma/status/1305608470738227203 …
Remdesivir -> Predicted positive
Hydroxychloroquine -> Predicted negative
Lopinavir -> Predicted negative
Ritonavir -> Predicted negative
Baricitinib -> Predicted positive
Dexamethasone -> Predicted negative
Fostamatinib -> Predicted positive, initiated
Show this thread
